![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Slc7a10 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Slc7a10 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC7A10 mRNA | CTD | PMID:17942748 | Slc7a10 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | Slc7a10 (Mus musculus) | 6480464 | [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which more ... | CTD | PMID:29288687 | Slc7a10 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... | CTD | PMID:36041667 | Slc7a10 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Slc7a10 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of SLC7A10 mRNA | CTD | PMID:28973697 | Slc7a10 | Rat | 5-aza-2'-deoxycytidine | affects expression | ISO | SLC7A10 (Homo sapiens) | 6480464 | Decitabine affects the expression of SLC7A10 mRNA | CTD | PMID:23300844 | Slc7a10 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of SLC7A10 mRNA | CTD | PMID:24780913 | Slc7a10 | Rat | aflatoxin B1 | decreases methylation | ISO | SLC7A10 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of SLC7A10 intron | CTD | PMID:30157460 | Slc7a10 | Rat | aldehydo-D-glucose | multiple interactions | ISO | Slc7a10 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] more ... | CTD | PMID:37567420 | Slc7a10 | Rat | all-trans-retinoic acid | multiple interactions | ISO | Slc7a10 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLC7A10 mRNA | CTD | PMID:36189433 | Slc7a10 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SLC7A10 mRNA | CTD | PMID:35163327 | Slc7a10 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of SLC7A10 mRNA | CTD | PMID:16483693 | Slc7a10 | Rat | atrazine | increases expression | ISO | SLC7A10 (Homo sapiens) | 6480464 | Atrazine results in increased expression of SLC7A10 mRNA | CTD | PMID:22378314 | Slc7a10 | Rat | benzo[a]pyrene | increases methylation | ISO | SLC7A10 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of SLC7A10 promoter | CTD | PMID:27901495 | Slc7a10 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | SLC7A10 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in increased expression of SLC7A10 mRNA | CTD | PMID:28412506 | Slc7a10 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | SLC7A10 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of SLC7A10 mRNA | CTD | PMID:31163220 | Slc7a10 | Rat | bisphenol A | increases expression | ISO | Slc7a10 (Mus musculus) | 6480464 | bisphenol A results in increased expression of SLC7A10 mRNA | CTD | PMID:38701888 | Slc7a10 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SLC7A10 mRNA | CTD | PMID:36779543 | Slc7a10 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... | CTD | PMID:36041667 | Slc7a10 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SLC7A10 mRNA | CTD | PMID:34947998 | Slc7a10 | Rat | bisphenol F | decreases expression | ISO | Slc7a10 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of SLC7A10 mRNA | CTD | PMID:38685157 | Slc7a10 | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... | CTD | PMID:36041667 | Slc7a10 | Rat | butanal | increases expression | ISO | SLC7A10 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of SLC7A10 mRNA | CTD | PMID:26079696 | Slc7a10 | Rat | carbon nanotube | decreases expression | ISO | Slc7a10 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of SLC7A10 mRNA; Nanotubes, Carbon results in decreased more ... | CTD | PMID:25554681 | Slc7a10 | Rat | cefaloridine | increases expression | EXP | | 6480464 | Cephaloridine results in increased expression of SLC7A10 mRNA | CTD | PMID:18500788 | Slc7a10 | Rat | chloroprene | decreases expression | ISO | Slc7a10 (Mus musculus) | 6480464 | Chloroprene results in decreased expression of SLC7A10 mRNA | CTD | PMID:23125180 | Slc7a10 | Rat | cisplatin | affects expression | ISO | SLC7A10 (Homo sapiens) | 6480464 | Cisplatin affects the expression of SLC7A10 mRNA | CTD | PMID:23300844 | Slc7a10 | Rat | copper(II) sulfate | decreases expression | ISO | SLC7A10 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of SLC7A10 mRNA | CTD | PMID:19549813 | Slc7a10 | Rat | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of SLC7A10 mRNA | CTD | PMID:26577399|PMID:27523638 | Slc7a10 | Rat | D-glucose | multiple interactions | ISO | Slc7a10 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] more ... | CTD | PMID:37567420 | Slc7a10 | Rat | dexamethasone | multiple interactions | ISO | Slc7a10 (Mus musculus) | 6480464 | [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which more ... | CTD | PMID:29288687 | Slc7a10 | Rat | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of SLC7A10 mRNA | CTD | PMID:21266533 | Slc7a10 | Rat | dicrotophos | increases expression | ISO | SLC7A10 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of SLC7A10 mRNA | CTD | PMID:28302478 | Slc7a10 | Rat | dioxygen | multiple interactions | ISO | Slc7a10 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC7A10 mRNA | CTD | PMID:30529165 | Slc7a10 | Rat | dorsomorphin | multiple interactions | ISO | SLC7A10 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Slc7a10 | Rat | entinostat | increases expression | ISO | SLC7A10 (Homo sapiens) | 6480464 | entinostat results in increased expression of SLC7A10 mRNA | CTD | PMID:26272509|PMID:27188386 | Slc7a10 | Rat | entinostat | multiple interactions | ISO | SLC7A10 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Slc7a10 | Rat | ethanol | increases expression | ISO | Slc7a10 (Mus musculus) | 6480464 | Ethanol results in increased expression of SLC7A10 mRNA | CTD | PMID:30319688 | Slc7a10 | Rat | fructose | multiple interactions | ISO | Slc7a10 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] more ... | CTD | PMID:37567420 | Slc7a10 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of SLC7A10 mRNA | CTD | PMID:22061828 | Slc7a10 | Rat | glucose | multiple interactions | ISO | Slc7a10 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] more ... | CTD | PMID:37567420 | Slc7a10 | Rat | ketamine | increases expression | EXP | | 6480464 | Ketamine results in increased expression of SLC7A10 mRNA | CTD | PMID:20080153 | Slc7a10 | Rat | lead diacetate | increases expression | ISO | Slc7a10 (Mus musculus) | 6480464 | lead acetate results in increased expression of SLC7A10 protein | CTD | PMID:25242007 | Slc7a10 | Rat | Licarin A | multiple interactions | ISO | Slc7a10 (Mus musculus) | 6480464 | [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which more ... | CTD | PMID:29288687 | Slc7a10 | Rat | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Slc7a10 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLC7A10 mRNA | CTD | PMID:36189433 | Slc7a10 | Rat | ozone | multiple interactions | ISO | Slc7a10 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased more ... | CTD | PMID:34911549 | Slc7a10 | Rat | panobinostat | multiple interactions | ISO | SLC7A10 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Slc7a10 | Rat | panobinostat | increases expression | ISO | SLC7A10 (Homo sapiens) | 6480464 | panobinostat results in increased expression of SLC7A10 mRNA | CTD | PMID:26272509 | Slc7a10 | Rat | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of SLC7A10 mRNA | CTD | PMID:32680482 | Slc7a10 | Rat | pentanal | increases expression | ISO | SLC7A10 (Homo sapiens) | 6480464 | pentanal results in increased expression of SLC7A10 mRNA | CTD | PMID:26079696 | Slc7a10 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SLC7A10 mRNA | CTD | PMID:35163327 | Slc7a10 | Rat | phosgene | affects expression | ISO | Slc7a10 (Mus musculus) | 6480464 | Phosgene affects the expression of SLC7A10 mRNA | CTD | PMID:16300373 | Slc7a10 | Rat | propanal | increases expression | ISO | SLC7A10 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of SLC7A10 mRNA | CTD | PMID:26079696 | Slc7a10 | Rat | pyrazinecarboxamide | decreases expression | EXP | | 6480464 | Pyrazinamide results in decreased expression of SLC7A10 mRNA | CTD | PMID:22431067 | Slc7a10 | Rat | SB 431542 | multiple interactions | ISO | SLC7A10 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Slc7a10 | Rat | sevoflurane | affects expression | EXP | | 6480464 | sevoflurane affects the expression of SLC7A10 mRNA | CTD | PMID:15967596 | Slc7a10 | Rat | sodium arsenite | increases expression | ISO | Slc7a10 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of SLC7A10 protein | CTD | PMID:31712840 | Slc7a10 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of SLC7A10 mRNA | CTD | PMID:34492290 | Slc7a10 | Rat | titanium dioxide | decreases expression | ISO | Slc7a10 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of SLC7A10 mRNA | CTD | PMID:23557971|PMID:27760801 | Slc7a10 | Rat | titanium dioxide | decreases methylation | ISO | Slc7a10 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of SLC7A10 promoter | CTD | PMID:35295148 | Slc7a10 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of SLC7A10 mRNA | CTD | PMID:33387578 | Slc7a10 | Rat | trichostatin A | increases expression | ISO | SLC7A10 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of SLC7A10 mRNA | CTD | PMID:24935251 | Slc7a10 | Rat | triclosan | increases expression | ISO | SLC7A10 (Homo sapiens) | 6480464 | Triclosan results in increased expression of SLC7A10 mRNA | CTD | PMID:30510588 | Slc7a10 | Rat | trimellitic anhydride | decreases expression | ISO | Slc7a10 (Mus musculus) | 6480464 | trimellitic anhydride results in decreased expression of SLC7A10 mRNA | CTD | PMID:19042947 | Slc7a10 | Rat | troglitazone | increases expression | ISO | Slc7a10 (Mus musculus) | 6480464 | troglitazone results in increased expression of SLC7A10 mRNA | CTD | PMID:28973697 | Slc7a10 | Rat | valproic acid | affects expression | ISO | SLC7A10 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SLC7A10 mRNA | CTD | PMID:25979313 | Slc7a10 | Rat | valproic acid | increases expression | ISO | SLC7A10 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SLC7A10 mRNA | CTD | PMID:19101580|PMID:23179753|PMID:24383497|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799 | Slc7a10 | Rat | valproic acid | multiple interactions | ISO | SLC7A10 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Slc7a10 | Rat | zidovudine | decreases expression | ISO | SLC7A10 (Homo sapiens) | 6480464 | Zidovudine results in decreased expression of SLC7A10 mRNA | CTD | PMID:24292225 | Slc7a10 | Rat | zidovudine | increases expression | ISO | SLC7A10 (Homo sapiens) | 6480464 | Zidovudine results in increased expression of SLC7A10 mRNA | CTD | PMID:24292225 | |